Anxiety Subtypes Show Opposite Epigenetic Aging Patterns Linked to Social Behavior

Anxiety disorders affect roughly 30% of people over a lifetime, yet their biological underpinnings — particularly at the epigenetic level — remain poorly characterized. Epigenetic clocks estimate biological age from DNA methylation (DNAm) patterns and have revealed accelerated or suppressed aging in schizophrenia, depression, and PTSD. This study asked whether similar patterns exist across anxiety disorder subtypes and whether social functioning explains any differences.

Researchers enrolled 30 anxiety disorder patients (11 SAD, 11 PD, 8 GAD) and 266 healthy controls from a Japanese cohort. Blood DNAm was measured using Illumina MethylationEPIC arrays, and epigenetic age acceleration was estimated using the PCHannumG2013 clock as the primary measure, with four additional clocks for sensitivity analyses. Social functioning was assessed with the validated Social Functioning Scale (SFS), covering domains from interpersonal communication to prosocial activities and employment.

The headline finding: SAD patients had significantly suppressed epigenetic age acceleration — their biological age ran younger than their chronological age compared to healthy controls. This was consistent across multiple clock types, with the exception of the DunedinPACE pace-of-aging clock. PD patients showed a marginal trend toward acceleration. GAD results were less definitive, likely due to the small sample. Lower SFS scores — particularly impaired independence-competence and reduced prosocial activities — were significantly associated with suppressed epigenetic aging across the full cohort.

Meta-analyses pooling this cohort with two prior DNAm-based anxiety disorder studies (totaling 423 healthy individuals and 278 anxiety patients) reinforced these subtype differences: suppressed aging in SAD reached statistical significance, while the elevation in PD remained a trend.

The authors propose two mechanistic interpretations. In SAD, the characteristic social avoidance may reduce exposure to social stressors that typically accelerate biological aging, creating a paradoxical protective effect on the epigenetic clock. This aligns with population-level findings that social isolation accelerates aging — but in SAD, voluntary avoidance may limit physiological stress load. In PD, recurrent panic attacks trigger acute autonomic arousal and inflammatory cascades, which may nudge epigenetic aging upward over time. These divergent pathways highlight that 'anxiety disorder' is not a biologically uniform category.

Key caveats include the small patient sample (especially GAD at n=8), a predominantly female anxiety group compared to a predominantly male control group, cross-sectional design preventing causal inference, and the use of blood-derived DNAm which may not reflect brain aging. Medication effects and comorbid conditions were minimized by exclusion criteria, but cannot be fully ruled out.